Latest filing published 13 Mar 2026 for CG Oncology, Inc., €96k.
Insider track record
Arthur Kuan: trading record in brief
Arthur Kuan discloses dealings in CG Oncology, Inc. to SEC (Form 4). Over a trading history stretching from 4 March 2026 to 12 March 2026, the count stands at 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 13 March 2026 came the latest disclosure, a share grant for €96k in CG Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arthur Kuan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,847 shares@ US$60.1519.4% of flowCommon StockSEC:0002007101-26-000004:1
- 64,612 shares@ US$1.7238.7% of flowCommon StockSEC:0002007101-26-000004:0
- 2,871 shares@ US$61.6130.6% of flowCommon StockSEC:0002007101-26-000002:1
- 102,871 shares@ US$1.7261.3% of flowCommon StockSEC:0002007101-26-000002:0
4 of 4 declarations
